PL EN


Preferences help
enabled [disable] Abstract
Number of results
2015 | 86 | 11 | 544-551
Article title

Liver Resection for Non-Colorectal, Non-Endocrine Liver Metastasis

Content
Title variants
Languages of publication
EN
Abstracts
Keywords
Publisher
Year
Volume
86
Issue
11
Pages
544-551
Physical description
Dates
received
1 - 9 - 2014
online
3 - 2 - 2015
References
  • 1. Dudek K: Czynniki optymalizacji chirurgicznego leczenia chorych z przerzutami raka jelita grubego do wątroby w zależności od stopnia zaawansowania”. Wyd. 1, Oficyna Wydawnicza Warszawskiego Uniwersytetu Medycznego; Warszawa 2013.
  • 2. Adam R, Chiche L, Aloia T et al.: Association Francaise de C. Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model. Ann surg 2006; 244: 524-35.
  • 3. de Ridder J, van Walsum m, Verhoef c et al.: Dutch Liver Working G. Hepatic resection for metastatic melanoma in The Netherlands: survival and prognostic factors. Melanoma Res 2013; 23: 27-32.[Crossref]
  • 4. Weitz J, Blumgart LH, Fong Y et al.: Partial hepatectomy for metastases from noncolorectal, nonneuroendocrine carcinoma. Ann surg 2005; 241: 269-76.
  • 5. Pawlik TM, Zorzi D, Abdalla EK et al.: Hepatic resection for metastatic melanoma: distinct patterns of recurrence and prognosis for ocular versus cutaneous disease. Ann Surg Oncology 2006; 13: 712-20.[Crossref]
  • 6. Groeschl RT, Nachmany I, Steel JL et al.: Hepa-tectomy for noncolorectal non-neuroendocrine metastatic cancer: a multi-institutional analysis. J Am Coll Surg 2012; 214: 769-77.
  • 7. Ercolani G, Grazi GL, Ravaioli M et al.: The role of liver resections for noncolorectal, nonneuroen-docrine metastases: experience with 142 observed cases. Ann Surg_ Oncol 2005; 12: 459-66.[Crossref]
  • 8. Elgadi K, Reichman T, Cleary SP: Evaluation and Management of Liver Metastases from Non-gastrointestinal Cancer. In: Brodt P, editor. Liver Metastasis: Biology and Clinical Management: Springer Science + Business Media B.V.; 2011.
  • 9. Er O, Frye DK, Kau SW, Broglio К et al.: Clinical course of breast cancer patients with metastases limited to the liver treated with chemotherapy. Cancer J 2008; 14: 62-68.[Crossref][PubMed]
  • 10. Adam R, Aloia T, Krissat J et al.: Is liver resection justified for patients with hepatic metastases from breast cancer? Ann Surg 2006; 244: 897-907.
  • 11. Belda T, Montalva EM, Lopez-Andujar R et al.: Role of resection surgery in breast cancer liver metastases. Experience over the last 10 years in a reference hospital. Cir Esp 2010; 88: 167-73.[Crossref]
  • 12. Vlastos G, Smith DL, Singletary SE et al.: Longterm survival after an aggressive surgical approach in patients with breast cancer hepatic metastases. Ann Surg Oncol 2004; 11: 869-74.[Crossref]
  • 13. Caralt M, Bilbao I, Cortes J et al.: Hepatic resection for liver metastases as part of the „oncosur-gical” treatment of metastatic breast cancer. Ann Surg Oncol 2008; 15: 2804-10.[Crossref]
  • 14. Thelen A, Benckert C, Jonas S et al.: Liver resection for metastases from breast cancer. J Surg Oncol 2008; 97: 25-9.[Crossref]
  • 15. d'Annibale M, Piovanello P, Cerasoli V et al.: Liver metastases from breast cancer: the role of surgical treatment. Hepatogastroenterology 2005; 52: 1858-62.
  • 16. Chua TC, Liauw W, Koong HN et al.: Surgical therapies in metastatic colorectal cancer with a potential for cure. Am J Clin Oncol 2011; 34: 326-31.[Crossref]
  • 17. Turkyilmaz A, Eroglu A, Aydin Y et al.: Survival in esophageal cancer patients with hematogenous distant organ metastases. Turk J Med Sci 2009; 39: 415-21.
  • 18. Quint Le, Hepburn Lm, Francis IR et al.: Incidence and distribution of distant metastases from newly diagnosed esophageal carcinoma. Cancer 1995; 76: 1120-25.[Crossref]
  • 19. Thelen A, Jonas S, Benckert C et al.: Liver resection for metastatic gastric cancer. Eur J surg oncol 2008; 34: 1328-34.[PubMed][Crossref]
  • 20. Koga R, Yamamoto J, Ohyama S et al.: Liver resection for metastatic gastric cancer: experience with 42 patients including eight longterm survivors. Jpn J clin oncol 2007; 37: 836-42.[Crossref]
  • 21. Dittmar Y, Altendorf-Hofmann A, Rauchfuss F et al.: Resection of liver metastases is beneficial in patients with gastric cancer: report on 15 cases and review of literature. Gastric Cancer 2012; 15: 131-36.[Crossref]
  • 22. Cheon SH, Rha SY, Jeung HC et al.: Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases. Ann Oncol 2008; 19: 1146-53.[Crossref]
  • 23. Elias D, Cavalcanti DE, Albuquerque A, Eggenspieler P et al.: Resection of liver metastases from a noncolorectal primary: indications and results based on 147 monocentric patients. J Am coll surg 1998; 187: 487-93.
  • 24. Laurent C, Rullier E, Feyler A et al.: Resection of noncolorectal and nonneuroendocrine liver metastases: late metastases are the only chance of cure. World J surg 2001; 25: 1532-36.[PubMed][Crossref]
  • 25. Kerkar SP, Kemp CD, Avital I: Liver resections in metastatic gastric cancer. HPB oxford 2010; 12: 589-96.[Crossref][PubMed]
  • 26. Tsujimoto H, Ichikura T, Ono S et al.: Outcomes for patients following hepatic resection of metastatic tumors from gastric cancer. Hepatol int 2010; 4: 406-13.[Crossref]
  • 27. Takada T, Yasuda H, Amano H et al.: Simultaneous hepatic resection with pancreato-duode-nectomy for metastatic pancreatic head carcinoma: does it improve survival? Hepatogastroenterology 1997; 44: 567-73.
  • 28. Aloia T: Non-colorectal gastrointestinal liver metastases. In: Vauthey JN, editor. Liver Metastases. London: Springer-Verlag; 2009.
  • 29. Bilimoria KY, Bentrem DJ, Wayne JD et al.: Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann surg 2009; 249: 63-71.
  • 30. Dabaja BS, Suki D, Pro B et al.: Adenocarcino-ma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. cancer 2004; 101: 518-26.[Crossref]
  • 31. Gupta K, Miller JD, Li JZ et al.: Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review. cancer Treat Rev 2008; 34: 193-205.[PubMed][Crossref]
  • 32. Kim B, Louie AC: Surgical resection following interleukin 2 therapy for metastatic renal cell carcinoma prolongs remission. Arch surg 1992; 127: 1343-49.
  • 33. Aloia TA, Adam R, Azoulay D et al.: Outcome following hepatic resection of metastatic renal tumors: the Paul Brousse Hospital experience. HPB oxford 2006; 8: 100-05.[Crossref]
  • 34. Staehler MD, Kruse J, Haseke N et al.: Liver resection for metastatic disease prolongs survival in renal cell carcinoma: 12-year results from a retrospective comparative analysis. World J Urol 2010; 28: 543-47.
  • 35. Thelen A, Jonas S, Benckert C et al.: Liver resection for metastases from renal cell carcinoma. World J surg 2007; 31: 802-07.[PubMed][Crossref]
  • 36. Hatzaras I, Gleisner AL, Pulitano C et al.: A multi-institution analysis of outcomes of liver-directed surgery for metastatic renal cell cancer. HPB oxford 2012; 14: 532-38.[PubMed][Crossref]
  • 37. Bosl GJ, Motzer RJ: Testicular germ-cell cancer. N Engl J Med 1997; 337: 242-53.
  • 38. Hartmann JT, Rick O, Oechsle Ket al.: Role of postchemotherapy surgery in the management of patients with liver metastases from germ cell tumors. Ann surg 2005; 242: 260-66.[Crossref][PubMed]
  • 39. Yoon SS, Jarnagin WR, Fong Y et al.: Resection of recurrent ovarian or fallopian tube carcinoma involving the liver. Gynecol oncol 2003; 91: 383-88.[Crossref]
  • 40. Kawagishi N, shirahata Y, Ishida K et al.: Hepatic resection of giant metastatic tumor from clear cell carcinoma of the ovary. J Hepatobiliary Pancreat surg 2005; 12: 155-58.[PubMed]
  • 41. Abood G, Bowen M, Potkul R et al.: Hepatic resection for recurrent metastatic ovarian cancer. Am J surg 2008; 195: 370-73.
  • 42. Chalkiadakis GE, Lasithiotakis KG, Petrakis I et al.: Major hepatectomy and right hemicolectomy at the time of primary cytoreductive surgery for advanced ovarian cancer: report of a case. Int J Gynecol cancer 2005; 15: 1115-19.[Crossref][PubMed]
  • 43. Tangjitgamol S, Levenback CF, Beller U et al.: Role of surgical resection for lung, liver, and central nervous system metastases in patients with gynecological cancer: a literature review. Int J Gynecol cancer 2004; 14: 399-422.[PubMed][Crossref]
  • 44. Ileana E, Greillier L, Moutardier Vet al.: Surgical resection of liver non-small cell lung cancer metastasis: a dual weapon? Lung cancer 2010; 70: 221-22.[Crossref]
  • 45. Song HJ, Xue YL, Xu YH et al.: Rare metastases of differentiated thyroid carcinoma: pictorial review. Endocr Relat cancer 2011; 18: 165-74.[Crossref]
  • 46. Bradley PJ: Distant metastases from salivary glands cancer. oRL J otorhinolaryngol Relat spec 2001; 63: 233-42.[PubMed]
  • 47. Deshpande AH, Kelkar AA: Hepatic metastasis as an initial manifestation of salivary adenoid cystic carcinoma: Cytologic diagnosis. Diagn cytopathol 2009; 37: 45-47.[Crossref][PubMed]
  • 48. Kebebew E, Reiff E, Duh QY et al.: Extent of disease at presentation and outcome for adrenocor-tical carcinoma: have we made progress? World J Surg 2006; 30: 872-78.[Crossref]
  • 49. Ripley RT, Kemp CD, Davis JL et al.: Liver resection and ablation for metastatic adrenocortical carcinoma. Ann surg oncol 2011; 18: 1972-79.[Crossref][PubMed]
  • 50. Berruti A, Terzolo M, Sperone P et al.: Etoposi-de, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial. Endocr relat cancer 2005; 12: 657-66.[Crossref]
  • 51. Lendoire J, Mow M, Andriani O et al.: Liver resection for non-colorectal, non-neuroendocrine metastases: analysis of a multicenter study from Argentina. HPB (oxford) 2007; 9: 435-39.[PubMed]
  • 52. Orourke TR, Tekkis P, Yeung S et al.: Longterm results of liver resection for non-colorectal, non-neuroendocrine metastases. Ann surg oncol 2008; 15: 207-18.[Crossref]
  • 53. Ercolani G, Vetrone G, Grazi Gl et al.: The role of liver surgery in the treatment of non-colorectal non-neuroendocrine metastases (NCRNNE). Analysis of 134 resected patients. Minerva chir 2009; 64: 551-58.
  • 54. Lehner F, ramackers W, Bektas H et al.: (Liver resection for non-colorectal, non-neuroendocrine liver metastases–is hepatic resection justified as part of the oncosurgical treatment?). zentralbl chir 2009; 134: 430-36.
  • 55. Lubrano J, roman H, Tarrab S et al.: Liver resection for breast cancer metastasis: does it improve survival? surg today 2008; 38: 293-99.[Crossref]
  • 56. Meloni MF, Andreano A, Laeseke PF et al.: Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation - intermediate and long-term survival rates. radiology 2009; 253: 861-69.
  • 57. Garancini M, Uggeri F, Degrate L et al.: Surgical treatment of liver metastases of gastric cancer: is local treatment in a systemic disease worthwhile? HPB (oxford) 2012; 14: 209-15.
  • 58. Yang XW, Li Z, Liu K et al.: Correlation between the survival rate of the patients with synchronous hepatic metastases from gastric carcinoma after surgical resection and patient's index. chin Med J (Engl) 2012; 125: 747-51.
  • 59. Berney T, Mentha G, Roth AD et al.: Results of surgical resection of liver metastases from non-colorectal primaries. Br J surg 1998; 85: 1423-27.
  • 60. Yamada H, Hirano S, Tanaka E et al.: Surgical treatment of liver metastases from pancreatic cancer. HPB (Oxford) 2006; 8: 85-88.[PubMed]
  • 61. Gleisner AL, Assumpcao L, Cameron JL et al.: Is resection of periampullary or pancreatic adenocarcinoma with synchronous hepatic metastasis justified? cancer 2007; 110: 2484-92.[PubMed][Crossref]
  • 62. Hartwig W, Denneberg M, Bergmann F et al.: Acinar cell carcinoma of the pancreas: is resection justified even in limited metastatic disease? Am J surg 2011; 202: 23-27.
  • 63. Klein F, Puhl G, Guckelberger O et al.: The impact of simultaneous liver resection for occult liver metastases of pancreatic adenocarcinoma. Gastroenterol res Pract 2012; 939350.[PubMed]
  • 64. Benevento A, Boni L, Frediani L et al.: Result of liver resection as treatment for metastases from noncolorectal cancer. J surg oncol 2000; 74: 24-29.[Crossref]
  • 65. Kornasiewcz O: Wartość leczenia chirurgicznego chorych z przerzutami do wątroby innymi niż przerzuty z raka jelita grubego i nowotworów neu-roendokrynnych. Wyd. 1. Oficyna Wydawnicza Warszawskiego Uniwersytetu Medycznego; Warszawa 2013.
Document Type
Publication order reference
YADDA identifier
bwmeta1.element.-psjd-doi-10_2478_pjs-2014-0097
Identifiers
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.